HETEROGENEITY IN GP CONSULTATION COSTS IN HEALTH TECHNOLOGY ASSESSMENTS- EXPLANATIONS AND IMPLICATIONS.
Author(s)
Kelleher D1, O'Neill C2
1The National University of Ireland, Galway, Galway, Ireland, 2Queen's University Belfast, Belfast, UK
Presentation Documents
OBJECTIVES: The comparative analysis of a novel intervention’s cost-effectiveness across jurisdictions is predicated on the existence of comparable measures of cost and outcome. More than 10 years after the Centre for Health Economics at York published a review of methods for estimating the cost of healthcare services considerable heterogeneity remains in the reporting of costs. We compare the estimated cost of the most commonly accessed service - general practitioner services - to demonstrate the degree of heterogeneity and explore the sources and implications of that heterogeneity for cost-effectiveness analysis conducted across jurisdictions. METHODS: A literature review was undertaken to identify the cost of a GP consultation used in health technology assessments. To minimise heterogeneity related to differences in national income, only countries listed among the high-income group by the World Bank were selected for inclusion in the review. The cost of a GP consultation in 20 countries was obtained from published literature located through Pubmed. All costs were adjusted for inflation to their 2015 equivalent and converted to Irish Euro € using the OECD’s PPP conversion rates. RESULTS: Among the 20 countries for which GP consultation costs were found, the reported cost of a consultation ranged from €7 to €142. The mean cost was €46 with a standard deviation of €36. Cost estimates varied in antiquity from 2007 to 2015. A positive weakly significant correlation was observed between GP costs and a country’s per capita GDP. CONCLUSIONS: Evident heterogeneity in the cost of a GP consultation reflects more strongly methodological heterogeneity in the estimation of costs than variations in national income. Adapting model-based estimates of cost-effectiveness using local costs without considering the basis upon which costs are constructed will fail to produce comparable estimates of cost-effectiveness.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PHS94
Topic
Economic Evaluation, Health Policy & Regulatory, Health Service Delivery & Process of Care, Health Technology Assessment, Real World Data & Information Systems
Topic Subcategory
Approval & Labeling, Cost/Cost of Illness/Resource Use Studies, Decision & Deliberative Processes, Health & Insurance Records Systems, Health Care Research, Pricing Policy & Schemes
Disease
Multiple Diseases
Explore Related HEOR by Topic